Mereo BioPharma Group plc Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2023 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Mereo BioPharma Group plc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2023 to Q3 2024.
  • Mereo BioPharma Group plc Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 770M shares, a 12.4% increase year-over-year.
  • Mereo BioPharma Group plc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 659M shares, a 9.33% increase from 2022.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 770M +85.2M +12.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 712M +83.3M +13.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 700M +76.3M +12.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 659M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 685M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 628M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 624M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.